BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21503747)

  • 1. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results.
    Iwamoto Y; Kanda H; Yamakado K; Soga N; Arima K; Takeda K; Sugimura Y
    Fam Cancer; 2011 Sep; 10(3):529-34. PubMed ID: 21503747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
    Wessendorf J; König A; Heers H; Mahnken AH
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
    Park BK; Kim CK
    J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
    Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
    Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
    Park BK; Kim CK; Park SY; Shen SH
    Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
    Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
    Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].
    Nao T; Shimamoto T; Karashima T; Kamei M; Fukuhara H; Fukata S; Satake H; Ashida S; Yamasaki I; Kamata M; Inoue K; Yamanishi T; Ogawa Y; Ito S; Shuin T
    Hinyokika Kiyo; 2014 Sep; 60(9):415-20. PubMed ID: 25293793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative therapy by percutaneous radiofrequency ablation of renal cell carcinomas--therapeutic experiments of four patients with seven renal tumors--].
    Karashima T; Inoue K; Shimamoto T; Yamasaki I; Kamada M; Shuin T
    Hinyokika Kiyo; 2006 Apr; 52(4):241-7. PubMed ID: 16686349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser navigation for radiofrequency ablation.
    Varro Z; Locklin JK; Wood BJ
    Cardiovasc Intervent Radiol; 2004; 27(5):512-5. PubMed ID: 15383857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
    Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
    Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
    Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
    Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
    Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
    J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.
    Gao Y; Xu M; Xu ZF; Liu DW; Tu XA; Zheng YL; Wang DH; Sun XZ; Zheng FF; Qiu SP; Lü MD; Zhang YY; Xie XY; Deng CH
    J Xray Sci Technol; 2012; 20(1):121-9. PubMed ID: 22398592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal-pleural fistula after radiofrequency ablation of renal tumor in VHL patient].
    Mouracade P; Salin A; Rouach Y; Timsit MO; Joly D; Correas JM; Mejean A
    Prog Urol; 2011 Jun; 21(6):432-6. PubMed ID: 21620305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-guided radiofrequency ablation of a renal tumor abutting vascular pedicle in a patient with von Hippel Lindau disease.
    Park BK; Kim CK
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):840-2. PubMed ID: 19067041
    [No Abstract]   [Full Text] [Related]  

  • 17. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
    Dai Y; Covarrubias D; Uppot R; Arellano RS
    J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].
    Anai H; Nagata T; Sato T; Minoshima K; Horie M; Yoshiya K; Uchida H; Kichikawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2303-5. PubMed ID: 21224555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radio frequency ablation of small renal tumors: initial results.
    Pavlovich CP; Walther M; Choyke PL; Pautler SE; Chang R; Linehan WM; Wood BJ
    J Urol; 2002 Jan; 167(1):10-5. PubMed ID: 11743264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.